OCT 24, 2018 10:30 AM PDT

Chemometric Methods for Analysis of 2D 1H-13C Methyl NMR Spectra of Monoclonal Antibodies for Higher Order Structure Characterization

Speaker
  • Research Chemist, Macromolecular Structure and Function Group, National Institute of Standards and Technology (NIST)
    Biography
      Luke W. Arbogast is a Research Chemist in the Biomolecular Measurement Division at the National Institute of Standards and Technology (NIST). His current research focuses on the development and application of state-of-the-art two-dimensional NMR methods to characterize the structure of protein therapeutics. These methods are of particular interest to the biopharmaceutical industry where structural comparability studies are necessary for drug development, drug-quality testing and the benchmarking biosimilars against innovator reference products. In 2016, Luke received the Department of Commerce Silver Award for his work in this area. Prior to his current role at NIST, Luke was a National Research Council Postdoctoral Fellow at the Institute for Bioscience and Biotechnology Research in Rockville, Md. Luke received his B.S. in Chemistry from Virginia Commonwealth University and his Ph.D. in Chemistry from Johns Hopkins University.

    Abstract

    Two-dimensional (2D) 1H-13C methyl correlated NMR is increasingly being recognized as a powerful tool to characterize the higher order structure (HOS) of monoclonal antibody (mAb) therapeutics. 2D methyl NMR is well suited to the task as spectra can be readily be acquired on intact mAbs at natural isotopic abundance, and even small changes to chemical environment and structure manifest observable changes in the spectra, which can be interpreted at atomic resolution. This makes it possible to apply 2D NMR approaches directly to drug products in order to systematically characterize structural effects. Traditionally, such analysis has involved identifying specific changes to measured resonance peak parameters.  Recently, we have demonstrated a complementary approach using principal component analysis (PCA) to directly analyze the matrix of spectral data, correlating spectra according to similarities and differences in their overall shapes. This approach is particularly well-suited for spectra of mAbs, where many individual peaks may not be well resolved and peak parameters difficult to measure. Here we demonstrate the performance of the PCA method for discriminating structural variation among systematic sets of 2D NMR spectra using the NISTmAb reference material and illustrate how spectral variability identified by PCA may be correlated to structure.

    Learning Objectives: 

    1. 2D 1H-13C Methyl NMR spectra can be readily acquired on monoclonal antibody therapeutics at natural isotopic abundance.
    2. Such spectra are suitable to assess the major conformation(s) of mAb drugs in solution.
    3. Using multivariate statistics, such as principal component analysis mAb spectra can be classified based on minor structural perturbations with low levels of detection.


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    APR 20, 2021 11:00 AM PDT
    C.E. CREDITS
    APR 20, 2021 11:00 AM PDT
    Date: April 20, 2021 Time: 11:00am (PST), 2:00pm (EST) Identification and confirmation of microbial isolates is crucial in the analysis workflow, providing decision-makers the information...
    MAR 25, 2021 8:00 AM PDT
    C.E. CREDITS
    MAR 25, 2021 8:00 AM PDT
    Date: March 25, 2021 Time: 8:00am (PST), 11:00am (EST) Flow cytometry has expanded to have more users, more data, and multiple instrument types. While this has lead to more quantitative data...
    DEC 15, 2020 10:00 AM PST
    C.E. CREDITS
    DEC 15, 2020 10:00 AM PST
    DATE: December 15, 2020 TIME: 10:00am PST Scientists from Thermo Fisher Scientific will walk us through the world of microorganisms. They will discuss their most recent research on viruses,...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    OCT 24, 2018 10:30 AM PDT

    Chemometric Methods for Analysis of 2D 1H-13C Methyl NMR Spectra of Monoclonal Antibodies for Higher Order Structure Characterization


    Specialty

    Research And Development

    Automation

    Virology

    Microbiology

    Earth Science

    Immuno-Oncology

    University

    Clinical Diagnostics

    Physical Chemistry

    Protein

    Lc-Ms/ms

    Genetic Engineering

    Human Biology

    Oncology

    Laboratory Testing

    Geography

    North America60%

    Asia20%

    Oceania20%

    Registration Source

    Website Visitors100%

    Job Title

    Medical Laboratory Technician40%

    Research Scientist40%

    Student20%

    Organization

    Hospital40%

    Research Institute20%

    Manufacturer - Other20%

    Other20%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more